Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025)

Stoke Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 43.44% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (up 43.44% YoY), while the FY2025 annual figure was $1.8 million, up 43.44% from the prior year.
• Treasury Shares was $1.8 million for Q4 2025 at Stoke Therapeutics, up from $1.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.8 million in Q4 2025 to a low of $1.2 million in Q4 2024.
• Historically, Treasury Shares has averaged $1.5 million across 3 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares retreated 19.18% in 2024, then surged 43.44% in 2025.
• A 3-year view of Treasury Shares shows it stood at $1.5 million in 2023, then dropped by 19.18% to $1.2 million in 2024, then soared by 43.44% to $1.8 million in 2025.
• The last three Treasury Shares figures came in at $1.8 million (Q4 2025), $1.2 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.